TriSalus Life Sciences (TLSI) Amortization of Deferred Charges (2023 - 2026)
TriSalus Life Sciences' (TLSI) quarterly Amortization of Deferred Charges came in at $31000.0 in Q1 2026, down 82.08% year-on-year from $173000.0 in Q1 2025, and up 3200.0% quarter-over-quarter from -$1000.0 in Q4 2025.
TriSalus Life Sciences (TLSI) Amortization of Deferred Charges (2023 - 2026) Analysis & Trends
TriSalus Life Sciences' Amortization of Deferred Charges history runs 4 years deep, the most recent figure standing at $31000.0 for Q1 2026.
- On a quarterly basis, Amortization of Deferred Charges fell 82.08% year-over-year to $31000.0 in Q1 2026; TTM through Mar 2026 was $1.4 million, a 8.07% increase from a year earlier, with the FY2025 full-year figure at $766000.0, up 190.15% from the prior year.
- Amortization of Deferred Charges grew to $31000.0 in Q1 2026 per TLSI's latest filing, from -$1000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $766000.0 in Q2 2025 and bottomed at -$130000.0 in Q4 2023.
- The 4-year median for Amortization of Deferred Charges is $130000.0 (2023), against an average of $206230.8.
- Across the five-year window, Amortization of Deferred Charges soared 2254.55% in 2024 and sank 100.21% in 2025, its largest moves.
- Year by year, Amortization of Deferred Charges stood at -$130000.0 in 2023, then jumped by 473.85% to $486000.0 in 2024, then plunged by 100.21% to -$1000.0 in 2025, then jumped by 3200.0% to $31000.0 in 2026.
- Per Business Quant, the three latest TLSI Amortization of Deferred Charges figures stand at $31000.0 (Q1 2026), -$1000.0 (Q4 2025), and $557000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.30 Bn | 175.00 Bn | 6.27 Bn |
| 2 | Stryker | 128.77 Bn | 125.89 Bn | 3.81 Bn |
| 3 | Medtronic | 107.99 Bn | 98.77 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.85 Bn | 66.39 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.12 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.98 Bn | 25.70 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.78 Bn | 20.65 Bn | 2.07 Bn |
| 10 | TriSalus Life Sciences | 225.23 Mn | 168.68 Mn | 7.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31,000.00 |
| Mar 31, 2026 | 31,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Sep 30, 2025 | 557,000.00 |
| Sep 30, 2025 | 557,000.00 |
| Jun 30, 2025 | 766,000.00 |
| Jun 30, 2025 | 766,000.00 |
| Mar 31, 2025 | 173,000.00 |
| Mar 31, 2025 | 173,000.00 |
| Dec 31, 2024 | 486,000.00 |
| Dec 31, 2024 | 486,000.00 |
| Sep 30, 2024 | 356,000.00 |
| Sep 30, 2024 | 356,000.00 |
| Jun 30, 2024 | 237,000.00 |
| Jun 30, 2024 | 237,000.00 |
| Mar 31, 2024 | 76,000.00 |
| Mar 31, 2024 | 76,000.00 |
| Dec 31, 2023 | -130,000.00 |
| Dec 31, 2023 | -130,000.00 |